GenomeWeb spoke with PRIMED investigators for this article highlighting how PRIMED is improving genetic risk estimates in diverse global populations. The piece features contributions from Consortium members Iftikhar Kullo, James Meigs, Jaewon Choi, and Soo-Heon Kwak in advancing PRS for type 2 diabetes and cardiovascular disease.
Source
GenomeWeb
Date
08/22/2024